PositiveID and GenAr
PositiveID and GenArraytion Partner on Firefly Dx
04. August 2015 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Aug. 04, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, and...
PositiveID Corporati
PositiveID Corporation Receives Nucleic Acids From the CDC Influenza Division to Develop a Diagnostic Assay to Detect H5N1 Avian Flu
28. März 2012 08:29 ET | PositiveID Corporation
DELRAY BEACH, Fla., March 28, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...
PositiveID Corporati
PositiveID Corporation Announces Second Quarter 2011 Accomplishments and Mid-Year Update
23. August 2011 08:00 ET | PositiveID Corporation
Mid-year highlights include the submission of iglucose 510(k) to the FDA and U.S. Department of Homeland Security validation of the Company's recently launched multiplex biothreat assay Additional...
U.S. Department of H
U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study
11. August 2011 08:00 ET | PositiveID Corporation
DHS' Science and Technologies Division Confirms Performance of the PSIDMBA New Website Available at www.psidmba.com DELRAY BEACH, Fla., Aug. 11, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation...
PositiveID Corporati
PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind
21. Juni 2011 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., June 21, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...